Please observe: you can be unable to buy articles on Cambridge Core between 8.00am and 11.00am (BST) on Tuesday 11 Might. In case you have any pressing queries, please go to the assistance pages to contact our customer support group.
We use cookies to differentiate you from different customers and to give you a greater expertise on our web sites. Shut this message to simply accept cookies or learn the way to handle your cookie settings.
Article contents
Summary
Key phrases
Strategies
Outcomes – “calcium microcrystalline hydroxyapatite”
The baseline scientific and biochemical traits of members are introduced in Desk 1. The teams had been comparable in all indices at baseline. Over the 3-month research interval, 85 % of members took 80 % or extra of their allotted capsules. Median compliance was not totally different between the teams (P= 0·10).
Dialogue
Within the current research, the ingestion of 1 g Ca as citrate, carbonate or MCH resulted in an acute and sustained elevation of serum Ca concentrations and suppression of bone resorption. As well as, after 3 months of supplementation, there was a discount in bone turnover (mirrored in each CTX and PINP ranges). Ingestion of MCH resulted in a smaller enhance in serum Ca concentrations than the consumption of typical citrate and carbonate dietary supplements, however elevated the concentrations of phosphate and the Ca–phosphate product.
Ionised and whole Ca concentrations remained elevated above baseline and the management group 8 h after a 1 g dose of Ca. Some research have reported elevations in serum Ca concentrations as much as 6 h after an oral dose(
Reference Karkkainen, Wiersma and Lamberg-Allardt
7
,
Reference Deroisy, Zartarian and Meurmans
24
,
Reference Horowitz, Wishart and Goh
25
), however few have continued past this time level. In postmenopausal ladies, serum Ca focus was considerably larger than the management 3–12 h after the ingestion of calcium carbonate and 1–9 h after the ingestion of calcium citrate(
Reference Heaney, Dowell and Bierman
6
). Equally, in postmenopausal ladies, a night dose of calcium carbonate or citrate raised serum Ca concentrations for a minimum of 12 h(
Reference Thomas, Want and Tucker
26
). Moreover, within the current research, the serum Ca tour was not totally different when calcium citrate was taken at baseline, or after 3 months of steady supplementation. In longitudinal research(
Reference Slinin, Blackwell and Ishani
8
), variations in serum Ca concentrations of the magnitude noticed within the current research are related to a 17 % enhance in cardiovascular danger, similar to that discovered within the trials of Ca supplementation(
Reference Bolland, Gray and Avenell
27
).
Few research have in contrast the acute results of MCH with different types of Ca. According to our findings, these research have demonstrated smaller will increase in serum Ca concentrations and/or reductions in PTH concentrations following the ingestion of MCH in contrast with different Ca salts(
Reference Reid, Schooler and Hannan
21
,
Reference Deroisy, Zartarian and Meurmans
24
,
Reference Buclin, Jacquet and Burckhardt
28
). The smaller rise in serum Ca concentrations following the ingestion of MCH might have been as a result of a decrease bioavailability of Ca. This was instructed by the smaller AUC of ionised Ca following the ingestion of MCH in contrast with citrate–carbonate consumption. Alternatively, Ca might have been extra slowly absorbed from MCH due to gradual dissolution of the hydroxyapatite crystal within the gastrointestinal tract, and the necessity for hydrolysis of the protein matrix. Nonetheless, it must be famous that MCH was comparably efficient in lowering bone turnover, so it does obtain the identical therapeutic impact with a lesser enhance in serum Ca concentrations. In distinction to the considerably smaller impact of MCH on ionised Ca concentrations, the variations between the teams for whole Ca concentrations had been much less pronounced. Elevated serum phosphate concentrations may clarify the smaller impact of MCH on ionised v. whole Ca concentrations, since Ca complexes with phosphate.
We discovered no variations between the citrate and carbonate teams, or between the MCH teams. Calcium citrate is extra soluble than carbonate, and has been instructed to be extra absorbable and/or lead to a bigger enhance in serum Ca concentrations(
Reference Thomas, Want and Tucker
26
,
Reference Nicar and Pak
29
,
Reference Harvey, Zobitz and Pak
30
), though others have discovered no distinction(
Reference Karp, Ketola and Lamberg-Allardt
5
,
Reference Heaney, Dowell and Bierman
6
,
Reference Deroisy, Zartarian and Meurmans
24
). Solubility performs a restricted position in figuring out Ca absorption, when Ca is run with a meal to wholesome individuals(
Reference Recker
31
,
Reference Heaney, Recker and Weaver
32
). Variations between calcium carbonate and citrate in some trials may replicate variations within the bodily type wherein they had been administered (e.g. powder v. pill)(
Reference Ekman, Reizenstein and Teigen
33
). Within the current research, all preparations had been administered as an identical encapsulated powders. Equally, the extra finely processed MCH preparation can be anticipated to be extra quickly absorbed than the much less finely processed preparation, as a result of larger floor space of the smaller particles, however this was not the noticed final result.
PTH reveals a marked diurnal rhythm(
Reference el-Hajj Fuleihan, Klerman and Brown
34
), as do markers of bone resorption, akin to CTX(
Reference Greenspan, Dresner-Pollak and Parker
35
–
Reference Qvist, Christgau and Pedersen
37
). Accordingly, we noticed vital adjustments within the concentrations of PTH and CTX within the management group of the current research through the 8 h interval; these adjustments had been similar to these beforehand reported for PTH(
Reference el-Hajj Fuleihan, Klerman and Brown
34
) and CTX(
Reference Qvist, Christgau and Pedersen
37
). The citrate–carbonate and MCH preparations additional lowered CTX concentrations over 8 h in contrast with the management. Markers of bone formation, akin to PINP, exhibit a diurnal rhythm just like these of bone resorption, however one that’s much less pronounced(
Reference Ahmad, Hopkins and Fraser
38
). PINP focus was solely measured at 8 h, and was elevated in all teams presently. After 3 months, bone turnover was considerably decrease within the citrate–carbonate and MCH teams, mirrored by reductions in each CTX and PINP concentrations. Lowered bone turnover is a well-established impact of Ca supplementation(
Reference Reid, Schooler and Hannan
21
,
Reference Riggs, O’Fallon and Muhs
39
–
Reference Reid, Ames and Mason
41
).
Earlier research have in contrast the acute results of various Ca preparations on serum Ca and PTH concentrations(
Reference Heaney, Dowell and Bierman
6
,
Reference Reid, Schooler and Hannan
21
,
Reference Deroisy, Zartarian and Meurmans
24
,
Reference Harvey, Zobitz and Pak
30
), below the premise that bigger will increase in ionised Ca concentrations and reductions in PTH concentrations will translate into larger suppression of bone turnover. Nonetheless, few have in contrast the long-term results of various Ca preparations on markers of bone turnover. Regardless of the variations that we noticed within the concentrations of ionised Ca, phosphate and PTH between the MCH and citrate–carbonate teams, their results on CTX and PINP concentrations had been the identical, acutely and after 3 months of therapy. Constantly, in longer trials, MCH has been as efficient as calcium carbonate in slowing bone loss(
Reference Ruegsegger, Keller and Dambacher
42
–
Reference Ciria-Recasens, Blanch-Rubio and Coll-Batet
44
). These findings recommend that the acute results of Ca preparations on serum Ca concentrations may be disassociated from their longer-term results on bone turnover.
Phosphate focus was elevated within the MCH group at 4 h in contrast with the management and citrate–carbonate teams. Individuals allotted to the MCH therapy would have obtained a further 0·5 g phosphate (based mostly on a Ca:phosphate ratio in bone of 1·5) in contrast with these allotted to the opposite therapy teams. As larger concentrations of serum phosphate and the Ca–phosphate product have been related to elevated CVD danger within the normal inhabitants(
Reference Shin, Kim and Chang
10
,
Reference Foley, Collins and Ishani
45
–
Reference Dhingra, Sullivan and Fox
47
), this implies that MCH may not present a safer type of supplemental Ca.
A weak spot of the current research was the dimensions of the dose of Ca studied. As in earlier comparable trials(
Reference Karp, Ketola and Lamberg-Allardt
5
,
Reference Heaney, Dowell and Bierman
6
,
Reference Deroisy, Zartarian and Meurmans
24
,
Reference Thomas, Want and Tucker
26
), we examined the results of 1 g Ca to maximise the variations between the preparations. Nonetheless, 1 g/d of supplemental Ca would generally be taken in two doses of 0·5–0·6 g, and day by day adjustments in serum Ca concentrations could also be smaller however probably of a larger period than that reported right here. Most trials within the meta-analysis of Ca and cardiovascular occasions(
Reference Bolland, Gray and Avenell
27
) administered 1 g/d of Ca in two divided doses, so any enhance in cardiovascular danger could also be associated to such a dosing schedule.
In abstract, typical calcium citrate and carbonate dietary supplements raised serum Ca concentrations for a minimum of 8 h, and this impact was not diminished with steady use. MCH produced a smaller enhance in ionised Ca concentrations, and a touch smaller discount in PTH concentrations, however had equal results on bone turnover to the standard Ca dietary supplements. Nonetheless, elevated concentrations of serum phosphate and the Ca–phosphate product after the MCH therapy recommend that it could not present a safer type of supplemental Ca. Consuming Ca by way of dietary sources is presently the most secure approach for individuals to realize their beneficial Ca consumption. For these unable to eat satisfactory Ca by way of weight-reduction plan alone, future analysis ought to purpose at figuring out the types of supplemental Ca that launch Ca into the blood slowly. The findings of the current research recommend that Ca preparations with smaller results on serum Ca concentrations should retain comparable efficacy in suppressing bone turnover.
Acknowledgements
The current research was supported by PharmaZen Restricted and the Well being Analysis Council of New Zealand. S. M. B. is the recipient of a College of Auckland Doctoral Scholarship.
The research sponsors had no position within the conduct of the research, the evaluation of the samples and knowledge, the interpretation of the findings or the writing of this text.
The authors’ contributions are as follows: S. M. B. and I. R. R. formulated the analysis query and designed the research; S. M. B., A. S., L. H., M. E. H., O. A., B. M. and A. M. H. carried out the research; G. D. G., S. M. B. and I. R. R. analysed the information and S. M. B. and I. R. R. drafted the manuscript, which was critically revised by the co-authors.
Not one of the authors has any battle of curiosity to declare.